Sonoma Pharmaceuticals Inc
F:O8Z3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sonoma Pharmaceuticals Inc
F:O8Z3
|
US |
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
Commercial Metals Co
NYSE:CMC
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is O8Z3's stock price target?
Not Available
O8Z3 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sonoma Pharmaceuticals Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 24%.
What is the Gross Profit forecast for Sonoma Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 6 years is 10%.